AUTHOR=Marseille Elliot , Stauffer Christopher S. , Agrawal Manish , Thambi Paul , Roddy Kimberly , Mithoefer Michael , Bertozzi Stefano M. , Kahn James G. TITLE=Group psychedelic therapy: empirical estimates of cost-savings and improved access JOURNAL=Frontiers in Psychiatry VOLUME=Volume 14 - 2023 YEAR=2023 URL=https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1293243 DOI=10.3389/fpsyt.2023.1293243 ISSN=1664-0640 ABSTRACT=Objective: To compare group and individual psychedelic-assisted therapy in terms of clinician time, costs and patient access.Methods: Using 2023 data from two group therapy trial sites, one using 3,4-Methylenedioxy methamphetamine (MDMA) to treat posttraumatic stress disorder (PTSD), and one using psilocybin to treat major depressive disorder (MDD), we compared overall variable costs, clinician costs and clinician time required by therapy protocols utilizing groups versus individual patient therapy. Using published literature, we estimated the prevalence of adults with PTSD and MDD eligible for treatment with psychedelic therapy and projected the savings in time and cost required to treat these prevalent cases.